Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Demuth, K.
Right arrow Articles by London, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Demuth, K.
Right arrow Articles by London, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 2 373-381, Copyright © 1998 by Oxford University Press

ORIGINAL ARTICLES

Endothelin and cardiovascular remodelling in end-stage renal disease

K Demuth, J Blacher, A Guerin, M Benoit, N Moatti, M Safar and G London
Department of Biochemistry, Broussais Hopital, Paris, France; INSERM Unite 337, Paris, France; Service de Nephrologie-Hemodialyse, Hopital Manhes, 8 Grande Rue, F-91700 Fleury-Merogis, France; Corresponding author

Background. Plasma endothelin (ET) is elevated in end-stage renal disease (ESRD), but the origin and consequences of this increase remain unclear. In the present study we analysed the relationships between plasma ET levels and cardiovascular alterations in ESRD. Methods and results. Common carotid artery (CCA) intima-media thickness (IMT) and diameter, atherosclerotic plaque occurrence, and left ventricular (LV) geometry and function were determined by ultrasound imaging in 76 haemodialysis patients and in 57 age-, sex-, and blood pressure-matched controls. Arterial stiffness was evaluated via carotid-femoral pulse wave velocity (CF-PWV), forearm post-ischaemic vasodilation was measured by venous plethysmography, and plasma ET levels were determined using a specific immunoenzymoassay. Compared with controls, ESRD patients had elevated plasma ET levels (1.6±1.4 vs 4.6±3.8 pg/ml; P<0.001), increased LV mass (P<0.001), increased CCA-IMT (P<0.001), a higher prevalence of atherosclerotic plaques (P<0.001) and increased CF-PWV (P<0.01). Plasma ET levels correlation positively with LV outflow velocity integral (r=0.57; P<0.0001), stroke index (P<0.01), and baseline forearm blood flow (P<0.001) which were all significantly higher in ESRD patients than in controls (P<0.01). After adjustment for age, blood pressure, haemoglobin levels, gender and body dimensions, plasma ET levels were significantly correlated to LV mass (r=0.46; P<0.001), CCA-IMT and CCA intima -media cross-sectional area (r=0.41; P<0.001), and CF-PWV (p<0.05). Post-ischaemic forearm vasodilation was decreased in ESRD (85±31 vs 119±28%; P<0.001) and there was a negative correlation between post-ischaemic flow recovery and ET levels (r=-0.49; P<0.001). In ESRD patients, plasma ET levels were positively and independently correlated with the prevalence of CCA atherosclerotic plaque (P<0.01). Conclusions. These results indicate that the increased plasma ET levels in ESRD patients are associated with left ventricular hypertrophy and arterial intima-media thickening, suggesting that increased ET concentrations in ESRD patients may be of pathophysiological significance in the process of cardiovascular remodelling. Keywords: endothelin; ESRD; cardiovascular remodelling
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.